The structure of the dystrophin glycoprotein complex


Non-uniform refinement: adaptive regularization improves cryo-EM reconstruction. I. Properties of dystrophin-associated protein complexes

Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17 was published in 2020.

Kimanius et al. Data-driven regularization lowers the size barrier of cryo-EM structure determination. Nat Methods 21, 1216-1221, doi:10.1038/s41592-024-02304-8 (2024).

Goldberg, L. R. et al. A dystrophin missense mutation showing persistence of dystrophin and dystrophin-associated proteins yet a severe phenotype. Ann. Neurol. 44, 971–976 (1998).

Crawford, G. E. Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. J. Cell Biol. In 2000 there was a series of 150, 140, and 140.

The effects of -O-GalNAc and -O-Man glycan modifications on the mucine-like region of -dy are compared. The year 2021, the Glycobiology 31, 649–661.

Holt, K. H., Crosbie, R. H., Venzke, D. P. & Campbell, K. P. Biosynthesis of dystroglycan: processing of a precursor propeptide. February Lett. 468, 78–83.

The role of sarcospan in duchenne and Becker muscular dystrophy: a systematic review and meta-analysis

J. K., mah, and a few other people. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscular Disord 24, 482–491 (2014).

Muthu, Richardson, K. A. and A. J. were part of the same group. The crystal structures of dystrophin and utrophin spectrin repeats: implications for domain boundaries. PLoS ONE 7, e40066 (2012).

Ramaswamy, K. S. There is a lack of force in the muscles of mice and rats. J. Physiol. 589, 1195–1208 (2011).

Marshall, J. L. et al. Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice. That’s kind of dull. There is a work named “mol.” Genet. 21, 4378–4393 (2012).

Moreira, E. S. There was a missense sarcoglycan gene alterations that caused a severe phenotype and Frequency of limb-girdle muscular diseases in Brazil. J. Med. Genet. 35, 951–953 (1998).

Geis, T. et al. A novel disease-like phenotype with multicystic leucodystrophy is associated with a Homozygeygous dystroglycan mutation. Neurogenetics 14, 205–213 (2013).

M et al. was written by Saha Impact of PYROXD1 deficiency on cellular respiration and correlations with genetic analyses of limb-girdle muscular dystrophy in Saudi Arabia and Sudan. It was a part of the field of Physiol. Genomics 50, 929–939 (2018).

Piccolo, F. A founder deficiency in the -sarcoglycan gene may have preceded their migration out of India. Hum. Mol. Genet. 5, 2019–2022 (1996).

Johnson, K. et al. Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness. Skelet. They had Muscle 8 and 23.

It was shown that there is an association betweenmutations in the dystrophin gene and sporadic dilated cardiomyopathy. There’s a word for that. It’s Genet. Metab. 77, 119–126 (2002).

Cadherin domains and endo-fucoidases in the marine bacterium Saccharophagus degradans 2-40 are carbohydrate-binding modules

Fraiberg, M., Borovok, I., Bayer, E. A., Weiner, R. M. & Lamed, R. Cadherin domains in the polysaccharide-degrading marine bacterium Saccharophagus degradans 2-40 are carbohydrate-binding modules. J. Bacteriol. There are 195, 283–285 things to do in 2011.

The article was written by C. Vickers and was based on research done by the Institute for Policy Research. Endo-fucoidan hydrolases from glycoside hydrolase family 107 (GH107) display structural and mechanistic similarities to α-l-fucosidases from GH29. The J. B.A. has an article on the topic. Chem. 293, 18296–18308 (2018).

Macao, B. and Hard, T. discovered that the SEA domain of theMUC1 mucin is folded in an autoproteolysis manner. Nat. Struct. Mol. Biol. 13, 71–76 (2006).

There was a sarcoglycan complex in myocytes. There is a description of Eur. J. Biochem. 267, 640–648 (2000).

Source: Native DGC structure rationalizes muscular dystrophy-causing mutations

Crystal structure of bacteriophage dystrobrevin endosialides and dystrophin-myotendinous junctions

Stummeyer, K., Dickmanns, A., Muhlenhoff, M., Gerardy-Schahn, R. & Ficner, R. Crystal structure of the polysialic acid-degrading endosialidase of bacteriophage K1F. Nat. It’s called Struct. Mol. Biol. 12, 90–96 (2005).

Grady, R. M. et al. Roles of tyrosinephosphorylated and nonphosphorylated isoforms of dystrobrevin in Skeletal muscle and myotendinous junctions. J. Cell Biol. 160, 741–752 (2003).

R. M., John, and R.M. were authors. Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin–glycoprotein complex. Neuron 25, 279–293 (2000).

C. Ponting and others reported zinc fingers in dystrophin. The trends Biochem. Sci 21, 11–13 (1996).

Marshall, J. L. muscles are regenerated by the use of sarcospan-dependency Akt activation for Utrophin expression. J. Cell Biol. 197, 1009–1027 (2012).

Source: Native DGC structure rationalizes muscular dystrophy-causing mutations

Partner-protein recognition in microscopically regulated embryonic development: A reappraisal of the relationship between dystroglycan and muscle pathology

Susa, K J., Kruse, A C., and Blacklow present structure, dynamics and principles of partner-protein recognition. Trends Cell. https://doi.org/10.1016/j.tcb.2023.09.003 (2023).

R. A. and other authors are involved in the publication, ‘Williamson, R. a. Early embryo development can be disrupted by dystroglycan in mice. It’s a bit hard to believe. There’s a show called “Mol. Genet. 6, 831–841 (1997).

Miller, G., Peter, A. K., Espinoza, E., Heighway, J., and Crosbie have studied the relationship between Microspan and muscle pathology. J. Muscle Res. Cell Motil. 27, 545–558 (2006).

Yoshida, M. Biochemical evidence for association of dystrobrevin with the sarcoglycan–sarcospan complex as a basis for understanding sarcoglycanopathy. It was very dull. It’s called mol. There is a Genet. 9, 1033–1040 (2000).

Source: Native DGC structure rationalizes muscular dystrophy-causing mutations

New domain for the rhamnogalacturonidase A (P.69) virulence factor P.69 pertactin and its association with Duchenne muscular dystrophy

A new domain was identified for pectate lyse C, a plant virulence factor. Science 260, 1503–1507 (1993).

P. Emsley, Charles, I. G., and Fairweather collaborated on the structure of the virulence factor P.69 pertactin. Nature 381, 90– 92 was published in 1996.

There is a right-handed parallel helix in the rhamnogalacturonidase A crystal structure. Structure 5, 533–544 (1997).

Parvatiyar and M. S. are related. Duchenne muscular dystrophy-associated cardiomyopathy is prevented by the regulating of cardiac isoproterenol by sarcospan. J. Am. The heart is an association. 4, e002490.

Mitchell, R. D., Palade, P. & Fleischer, S. Purification of morphologically intact triad structures from skeletal muscle. J. Cell Biol. 96, 1008–1016 (1983).

Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169–4185 (2021).

Bepler, T. et al. Particle picking is possible in the use of positive-unlabeled neural networks. Nat. Methods 16, 1153–1160 (2019).

Rosenthal, P. B. & Henderson, R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. The journal J.mol. Biol. 333, 721–745 (2003).

Source: Native DGC structure rationalizes muscular dystrophy-causing mutations

Accurate Prediction of Biomolecular Interactions with AlphaFold 3: All-atom Structure Validation for Macromolecular Crystallography

J. Abramson wrote a paper. Accurate structure prediction of biomolecular interactions with AlphaFold 3. There is a Nature article on this topic in the December edition of the journal.

V. B., Chen, and others. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66 was published on 12th of January, 2010.